Support ASGCT

ASGCT offers year-round advertising, sponsorship, and talent recruitment opportunities to help you meet your marketing and strategic goals.


Please contact development@asgct.org to discuss your goals and learn about getting involved with ASGCT.


Annual Meeting

The 25th Annual Meeting was held May 16-19, 2022 in Washington D.C. Sponsorship, exhibiting, and advertising opportunities at the 26th Annual Meeting will be released later this year. If you would like to be notified when information is available, please email exhibits@asgct.org.

Advertising and Marketing

Advertise in ASGCT's E-Newsletters

With three regular publications to choose from, advertising in our e-newsletters is a great way to reach thousands of gene and cell therapy professionals! Learn more about advertisement options, plus audience and distribution information. Contact advertising@asgct.org to secure your placement.

Print Advertisements in the Molecular Therapy Family of Journals

ASGCT maintains four journals: Molecular Therapy, Nucleic Acids, Oncolytics, and Methods & Clinical Development. Advertisements in these journals are managed by the publisher, Cell Press. Please view this Cell Press Media Kit and email Jim Secretario for more information.

Connect with Job Seekers

Recruit and connect with the top talent in gene and cell therapy by posting job openings on the ASGCT Career Center. Discounted rates are available for ASGCT members!

Highlight open positions to ASGCT members with Featured Job posts in The Vector.

Advocacy & Strategic Alliances

Support ASGCT by sponsoring the Society's annual Policy Summit featuring expert presentations on legislative, regulatory, and ethical issues to advance the development of safe, efficient, and accessible gene therapies.

The 2022 Policy Summit will take place September 26-27 at the JW Marriott in Washington, D.C. and virtually. Learn more about sponsorship opportunities and ways to participate.

Patient Education

ASGCT’s patient-centered education website is designed to inform patients, families, and the general public on the status and promise of gene and cell therapies. Support scientific and reliable information by sponsoring our educational resources, videos, and infographics.

Watch our video about how these resources are developed, and learn about support opportunities.

ASGCT's Insight Series

Topics for this new series of webinars are each developed collaboratively by two ASGCT committees, resulting in new dynamic conversations. Reach these unique audiences with two sponsorship levels.

Awards and Grants

Help support ASGCT member research through these funded awards

The Career Development Awards support independent transformative pilot studies in gene and cell therapy by ASGCT members, particularly those ideas that would be challenging to fund with normal funding mechanisms. In 2022, we are awarding one $100,000 grant toward research in each of six broad topics, and the Cystic Fibrosis Foundation will support three more $100,000 awards, totaling $900,000 in funding.

The Underrepresented Minority Fellowship in Gene and Cell Therapy for Oncology will award $100,000 to a postdoctoral or early-career oncology researcher from a racial or ethnic minority group underrepresented in the scientific workforce.

The Underrepresented Population Fellowship Award in Gene and Cell Therapy for Any Indication will award $100,000 to a postdoctoral or early-career scientist from a group underrepresented in the scientific workforce who is engaged in any area of gene or cell therapy research.

The Award for Research on Conditions Disproportionately Affecting Minorities will provide $50,000 of funding for research focused on gene or cell therapy for conditions that disproportionately affect minority populations.

Upcoming Events

Connect with targeted audiences by supporting these upcoming events

Please contact development@asgct.org for more information about any of the above opportunities.

2022

ASGCT Policy Summit

September 26-27, 2022

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.